These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23812957)

  • 21. The importance of decision intent within descriptions of pragmatic trials.
    Nicholls SG; Zwarenstein M; Hey SP; Giraudeau B; Campbell MK; Taljaard M
    J Clin Epidemiol; 2020 Sep; 125():30-37. PubMed ID: 32422248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pragmatic randomized trials in drug development pose new ethical questions: a systematic review.
    Kalkman S; van Thiel GJ; Grobbee DE; van Delden JJ
    Drug Discov Today; 2015 Jul; 20(7):856-62. PubMed ID: 25794600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Commentary: considerations for using the 'Trials within Cohorts' design in a clinical trial of an investigational medicinal product.
    Bibby AC; Torgerson DJ; Leach S; Lewis-White H; Maskell NA
    Trials; 2018 Jan; 19(1):18. PubMed ID: 29310706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternative approaches to tuberculosis treatment evaluation: the role of pragmatic trials.
    Bratton DJ; Nunn AJ
    Int J Tuberc Lung Dis; 2011 Apr; 15(4):440-6. PubMed ID: 21396200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incentives and payments in pragmatic clinical trials: Scientific, ethical, and policy considerations.
    Garland A; Weinfurt K; Sugarman J
    Clin Trials; 2021 Dec; 18(6):699-705. PubMed ID: 34766524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Data monitoring committees for pragmatic clinical trials.
    Ellenberg SS; Culbertson R; Gillen DL; Goodman S; Schrandt S; Zirkle M
    Clin Trials; 2015 Oct; 12(5):530-6. PubMed ID: 26374679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Could phase 3 medicine trials be tagged as pragmatic? A case study: The Salford COPD trial.
    Dal-Ré R
    J Eval Clin Pract; 2018 Feb; 24(1):258-261. PubMed ID: 28685913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pragmatic study designs for older adults with cancer: Report from the U13 conference.
    Nipp RD; Yao NA; Lowenstein LM; Buckner JC; Parker IR; Gajra A; Morrison VA; Dale W; Ballman KV
    J Geriatr Oncol; 2016 Jul; 7(4):234-41. PubMed ID: 27197914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Social Value of Knowledge and International Clinical Research.
    Wenner DM
    Dev World Bioeth; 2015 Aug; 15(2):76-84. PubMed ID: 26195253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Application of pragmatic clinical trials in clinical evaluation of Chinese medicine].
    Wu YQ; Hu YH
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Dec; 30(12):1241-4. PubMed ID: 21302481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Explanatory and pragmatic clinical trials: a primer and application to a recent asthma trial.
    Sackett DL
    Pol Arch Med Wewn; 2011; 121(7-8):259-63. PubMed ID: 21878863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Making trials matter: pragmatic and explanatory trials and the problem of applicability.
    Treweek S; Zwarenstein M
    Trials; 2009 Jun; 10():37. PubMed ID: 19493350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethical considerations for outcome-adaptive trial designs: a clinical researcher's perspective.
    Saxman SB
    Bioethics; 2015 Feb; 29(2):59-65. PubMed ID: 24547903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A dynamic application of PRECIS-2 to evaluate implementation in a pragmatic, cluster randomized clinical trial in two nursing home systems.
    Palmer JA; Mor V; Volandes AE; McCreedy E; Loomer L; Carter P; Dvorchak F; Mitchell SL
    Trials; 2018 Aug; 19(1):453. PubMed ID: 30134976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Trial Portfolios: A Critical Oversight in Human Research Ethics, Drug Regulation, and Policy.
    London AJ; Kimmelman J
    Hastings Cent Rep; 2019 Jul; 49(4):31-41. PubMed ID: 31429954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Schemata, CONSORT, and the Salk Polio Vaccine Trial.
    Kowalski CJ; Mrdjenovich AJ
    J Med Philos; 2018 Jan; 43(1):64-82. PubMed ID: 29300977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethical issues in the design and conduct of stepped-wedge cluster randomized trials in low-resource settings.
    Joag K; Ambrosio G; Kestler E; Weijer C; Hemming K; Van der Graaf R
    Trials; 2019 Dec; 20(Suppl 2):703. PubMed ID: 31852547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Framing the conversation: use of PRECIS-2 ratings to advance understanding of pragmatic trial design domains.
    Lipman PD; Loudon K; Dluzak L; Moloney R; Messner D; Stoney CM
    Trials; 2017 Nov; 18(1):532. PubMed ID: 29126437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized controlled trials and neurosurgery: the ideal fit or should alternative methodologies be considered?
    Mansouri A; Cooper B; Shin SM; Kondziolka D
    J Neurosurg; 2016 Feb; 124(2):558-68. PubMed ID: 26315006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ethical responsibilities toward indirect and collateral participants in pragmatic clinical trials.
    Smalley JB; Merritt MW; Al-Khatib SM; McCall D; Staman KL; Stepnowsky C
    Clin Trials; 2015 Oct; 12(5):476-84. PubMed ID: 26374687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.